Global Insulin Like Growth Factor 1 Receptor Market Research Report 2019
Table of Contents
Executive Summary
1 Insulin Like Growth Factor 1 Receptor Market Overview
- 1.1 Product Overview and Scope of Insulin Like Growth Factor 1 Receptor
- 1.2 Insulin Like Growth Factor 1 Receptor Segment by Type
- 1.2.1 Global Insulin Like Growth Factor 1 Receptor Production Growth Rate Comparison by Type (2014-2025)
- 1.2.2 BI-893923
- 1.2.3 CT-707
- 1.2.4 1R-E1
- 1.2.5 ATL-1101
- 1.2.6 Others
- 1.3 Insulin Like Growth Factor 1 Receptor Segment by Application
- 1.3.1 Insulin Like Growth Factor 1 Receptor Consumption Comparison by Application (2014-2025)
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Others
- 1.3 Global Insulin Like Growth Factor 1 Receptor Market by Region
- 1.3.1 Global Insulin Like Growth Factor 1 Receptor Market Size Region
- 1.3.2 North America Status and Prospect (2014-2025)
- 1.3.3 Europe Status and Prospect (2014-2025)
- 1.3.4 China Status and Prospect (2014-2025)
- 1.3.5 Japan Status and Prospect (2014-2025)
- 1.3.6 Southeast Asia Status and Prospect (2014-2025)
- 1.3.7 India Status and Prospect (2014-2025)
- 1.4 Global Insulin Like Growth Factor 1 Receptor Market Size
- 1.4.1 Global Insulin Like Growth Factor 1 Receptor Revenue (2014-2025)
- 1.4.2 Global Insulin Like Growth Factor 1 Receptor Production (2014-2025)
2 Global Insulin Like Growth Factor 1 Receptor Market Competition by Manufacturers
- 2.1 Global Insulin Like Growth Factor 1 Receptor Production Market Share by Manufacturers (2014-2019)
- 2.2 Global Insulin Like Growth Factor 1 Receptor Revenue Share by Manufacturers (2014-2019)
- 2.3 Global Insulin Like Growth Factor 1 Receptor Average Price by Manufacturers (2014-2019)
- 2.4 Manufacturers Insulin Like Growth Factor 1 Receptor Production Sites, Area Served, Product Types
- 2.5 Insulin Like Growth Factor 1 Receptor Market Competitive Situation and Trends
- 2.5.1 Insulin Like Growth Factor 1 Receptor Market Concentration Rate
- 2.5.2 Insulin Like Growth Factor 1 Receptor Market Share of Top 3 and Top 5 Manufacturers
- 2.5.3 Mergers & Acquisitions, Expansion
3 Global Insulin Like Growth Factor 1 Receptor Production Market Share by Regions
- 3.1 Global Insulin Like Growth Factor 1 Receptor Production Market Share by Regions
- 3.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Regions (2014-2019)
- 3.3 Global Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 3.4 North America Insulin Like Growth Factor 1 Receptor Production
- 3.4.1 North America Insulin Like Growth Factor 1 Receptor Production Growth Rate (2014-2019)
- 3.4.2 North America Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 3.5 Europe Insulin Like Growth Factor 1 Receptor Production
- 3.5.1 Europe Insulin Like Growth Factor 1 Receptor Production Growth Rate (2014-2019)
- 3.5.2 Europe Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 3.6 China Insulin Like Growth Factor 1 Receptor Production (2014-2019)
- 3.6.1 China Insulin Like Growth Factor 1 Receptor Production Growth Rate (2014-2019)
- 3.6.2 China Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 3.7 Japan Insulin Like Growth Factor 1 Receptor Production (2014-2019)
- 3.7.1 Japan Insulin Like Growth Factor 1 Receptor Production Growth Rate (2014-2019)
- 3.7.2 Japan Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
4 Global Insulin Like Growth Factor 1 Receptor Consumption by Regions
- 4.1 Global Insulin Like Growth Factor 1 Receptor Consumption by Regions
- 4.2 North America Insulin Like Growth Factor 1 Receptor Consumption (2014-2019)
- 4.3 Europe Insulin Like Growth Factor 1 Receptor Consumption (2014-2019)
- 4.4 China Insulin Like Growth Factor 1 Receptor Consumption (2014-2019)
- 4.5 Japan Insulin Like Growth Factor 1 Receptor Consumption (2014-2019)
5 Global Insulin Like Growth Factor 1 Receptor Production, Revenue, Price Trend by Type
- 5.1 Global Insulin Like Growth Factor 1 Receptor Production Market Share by Type (2014-2019)
- 5.2 Global Insulin Like Growth Factor 1 Receptor Revenue Market Share by Type (2014-2019)
- 5.3 Global Insulin Like Growth Factor 1 Receptor Price by Type (2014-2019)
- 5.4 Global Insulin Like Growth Factor 1 Receptor Production Growth by Type (2014-2019)
6 Global Insulin Like Growth Factor 1 Receptor Market Analysis by Applications
- 6.1 Global Insulin Like Growth Factor 1 Receptor Consumption Market Share by Application (2014-2019)
- 6.2 Global Insulin Like Growth Factor 1 Receptor Consumption Growth Rate by Application (2014-2019)
7 Company Profiles and Key Figures in Insulin Like Growth Factor 1 Receptor Business
- 7.1 Astellas Pharma Inc.
- 7.1.1 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.1.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.1.4 Main Business and Markets Served
- 7.2 AstraZeneca Plc
- 7.2.1 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.2.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.2.4 Main Business and Markets Served
- 7.3 Axelar AB
- 7.3.1 Axelar AB Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.3.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.3.4 Main Business and Markets Served
- 7.4 Boehringer Ingelheim GmbH
- 7.4.1 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.4.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.4.4 Main Business and Markets Served
- 7.5 Bristol-Myers Squibb Company
- 7.5.1 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.5.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.5.4 Main Business and Markets Served
- 7.6 Eli Lilly and Company
- 7.6.1 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.6.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.6.4 Main Business and Markets Served
- 7.7 F. Hoffmann-La Roche Ltd.
- 7.7.1 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.7.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.7.4 Main Business and Markets Served
- 7.8 Genmab A/S
- 7.8.1 Genmab A/S Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.8.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.8.4 Main Business and Markets Served
- 7.9 Immunomedics, Inc.
- 7.9.1 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.9.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.9.4 Main Business and Markets Served
- 7.10 Insmed Incorporated
- 7.10.1 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
- 7.10.2 Insulin Like Growth Factor 1 Receptor Product Introduction, Application and Specification
- 7.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production, Revenue, Price and Gross Margin (2014-2019)
- 7.10.4 Main Business and Markets Served
- 7.11 Merck & Co., Inc.
- 7.12 Merrimack Pharmaceuticals, Inc.
- 7.13 Novartis AG
- 7.14 PharmAbcine, Inc.
- 7.15 ProteoThera, Inc.
8 Insulin Like Growth Factor 1 Receptor Manufacturing Cost Analysis
- 8.1 Insulin Like Growth Factor 1 Receptor Key Raw Materials Analysis
- 8.1.1 Key Raw Materials
- 8.1.2 Price Trend of Key Raw Materials
- 8.1.3 Key Suppliers of Raw Materials
- 8.2 Proportion of Manufacturing Cost Structure
- 8.3 Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor
- 8.4 Insulin Like Growth Factor 1 Receptor Industrial Chain Analysis
9 Marketing Channel, Distributors and Customers
- 9.1 Marketing Channel
- 9.1.1 Direct Marketing
- 9.1.2 Indirect Marketing
- 9.2 Insulin Like Growth Factor 1 Receptor Distributors List
- 9.3 Insulin Like Growth Factor 1 Receptor Customers
10 Market Dynamics
- 10.1 Market Trends
- 10.2 Opportunities
- 10.3 Market Drivers
- 10.4 Challenges
- 10.5 Influence Factors
11 Global Insulin Like Growth Factor 1 Receptor Market Forecast
- 11.1 Global Insulin Like Growth Factor 1 Receptor Production, Revenue Forecast
- 11.1.1 Global Insulin Like Growth Factor 1 Receptor Production Growth Rate Forecast (2019-2025)
- 11.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue and Growth Rate Forecast (2019-2025)
- 11.1.3 Global Insulin Like Growth Factor 1 Receptor Price and Trend Forecast (2019-2025)
- 11.2 Global Insulin Like Growth Factor 1 Receptor Production Forecast by Regions (2019-2025)
- 11.2.1 North America Insulin Like Growth Factor 1 Receptor Production, Revenue Forecast (2019-2025)
- 11.2.2 Europe Insulin Like Growth Factor 1 Receptor Production, Revenue Forecast (2019-2025)
- 11.2.3 China Insulin Like Growth Factor 1 Receptor Production, Revenue Forecast (2019-2025)
- 11.2.4 Japan Insulin Like Growth Factor 1 Receptor Production, Revenue Forecast (2019-2025)
- 11.3 Global Insulin Like Growth Factor 1 Receptor Consumption Forecast by Regions (2019-2025)
- 11.3.1 North America Insulin Like Growth Factor 1 Receptor Consumption Forecast (2019-2025)
- 11.3.2 Europe Insulin Like Growth Factor 1 Receptor Consumption Forecast (2019-2025)
- 11.3.3 China Insulin Like Growth Factor 1 Receptor Consumption Forecast (2019-2025)
- 11.3.4 Japan Insulin Like Growth Factor 1 Receptor Consumption Forecast (2019-2025)
- 11.4 Global Insulin Like Growth Factor 1 Receptor Production, Revenue and Price Forecast by Type (2019-2025)
- 11.5 Global Insulin Like Growth Factor 1 Receptor Consumption Forecast by Application (2019-2025)
12 Research Findings and Conclusion
13 Methodology and Data Source
- 13.1 Methodology/Research Approach
- 13.1.1 Research Programs/Design
- 13.1.2 Market Size Estimation
- 13.1.3 Market Breakdown and Data Triangulation
- 13.2 Data Source
- 13.2.1 Secondary Sources
- 13.2.2 Primary Sources
- 13.3 Author List
The global Insulin Like Growth Factor 1 Receptor market is valued at million US$ in 2018 is expected to reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Insulin Like Growth Factor 1 Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Like Growth Factor 1 Receptor market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and Japan.
At company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.
The following manufacturers are covered:
Astellas Pharma Inc.
AstraZeneca Plc
Axelar AB
Boehringer Ingelheim GmbH
Bristol-Myers Squibb Company
Eli Lilly and Company
F. Hoffmann-La Roche Ltd.
Genmab A/S
Immunomedics, Inc.
Insmed Incorporated
Merck & Co., Inc.
Merrimack Pharmaceuticals, Inc.
Novartis AG
PharmAbcine, Inc.
ProteoThera, Inc.
Segment by Regions
North America
Europe
China
Japan
Segment by Type
BI-893923
CT-707
1R-E1
ATL-1101
Others
Segment by Application
Hospital
Clinic
Others